On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…
On Feb. 27, 1992, Dr. Robert Adams and Dr. Virgil C. McKie of the Medical College of Georgia…
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
On Sept. 21, 1983, Sickle Cell Month was officially recognized nationally when the U.S. House of Representatives unanimously…
In 1975, Sickle Cell Disease Awareness Month originated when the Sickle Cell Disease Association of America and its…
In 1923, Dr. Virgil P. Sydenstricker published the first documented case of sickle cell disease, with full autopsy…